As you are aware, the use of plastics in various industries, has raised significant environmental concerns.

The environmental issues associated with plastics emphasize the importance of developing sustainable alternatives and paper manufacturers are developing sustainable alternatives that reduce dependency on plastics and offer a lower carbon footprint.

In a recent press release from UPM, it announced that UPM, Selenis and Bormioli Pharma introduce the world's first pharmaceutical bottle partially made with wood-based plastics.

The UPM press release states that "The collaboration is driven by a shared vision to support the pharmaceutical industry's move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM's carbon negative[1] BioMEG, are made from Selenis' Selcare's partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.

Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma's containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today, said Michael Duetsch, Vice President of Biochemicals at UPM."

You can read the full press release by clicking here.